Pairing a drug that targets the PRDM9 gene with a cholesterol-lowering agent shrank brain tumors and improved survival in mice.
In the big picture, matched sibling donor transplants remain the standard of care, Boelens said. But gene therapy is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback